Alpine Immune Shares Fall Premarket After Public Offering
By Colin Kellaher Shares of Alpine Immune Sciences fell nearly 10% in premarket trading Tuesday following the pricing of the clinical-stage immunotherapy...
Source: marketwatch.com
Page 27 - Alpine Immune Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Alpine Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Alpine Immune Sciences Today - Breaking & Trending Today
Alpine Immune Sciences Shares Rise 11% After Pricing Public Offering Of 8.8 Mln Shares
Shares of Alpine Immune Sciences, Inc. (ALPN) are falling more than 11% Tuesday morning after the clinical-stage immunotherapy company priced its public offering of 8.
Source: rttnews.com
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Adtran (NASDAQ:ADTN), Alpine Immune Sciences (NASDAQ:ALPN)
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
Source: benzinga.com
Alpine Immune Sciences Shares Rise 11% After Pricing Public Offering Of 8.8 Mln Shares
Shares of Alpine Immune Sciences, Inc. (ALPN) are falling more than 11% Tuesday morning after the clinical-stage immunotherapy company priced its public offering of 8.
Source: rttnews.com
Early RUBY-3 Data Shows Promise for Povetacicept in Glomerulonephritis
Preliminary data from the open-label RUBY-3 trial were presented at the American Society of Nephrology Kidney Week 2023.
Source: hcplive.com